INS and type 2 diabetes mellitus: Of those 21 studies on patients with T2DM, 3 included patients that were treated with exogenous insulin [34,35,36], while the rest allowed their participants to use glucose-lowering medications but instructed them to keep the same dosage throughout the study period.